Plasma NT-proBNP is a potential marker of disease severity and correlates with symptoms in patients with chronic rheumatic valve disease

European Journal of Heart Failure

Volumn 7, Issue 4, 2005, Pages 532-536

  Davutoglu, Vedat ^a   Celik, Ahmet ^a   Aksoy, Mehmet ^a   Sezen, Yusuf ^a   Soydinc, Serdar ^a   Gunay, Nurullah ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Echocardiography; Functional status; Mitral valve score; NT proBNP; Rheumatic valve disease

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AORTA STENOSIS; ARTICLE; BLOOD SAMPLING; CALCIFICATION; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM HYPERTROPHY; HEART ATRIUM THROMBOSIS; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MITRAL VALVE STENOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATIC HEART DISEASE; SCORING SYSTEM; SYMPTOM; TRICUSPID VALVE REGURGITATION; VENOUS BLOOD;

ADOLESCENT; ADULT; AGED; AORTIC VALVE INSUFFICIENCY; BIOLOGICAL MARKERS; CHRONIC DISEASE; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RHEUMATIC HEART DISEASE;

EID: 19544376098     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.07.006     Document Type: Article

References (13)

1. S.F. Rizvi, M.A. Khan, A. Kundi, D.R. Marsh, A. Samad, and O. Pasha Status of rheumatic heart disease in rural Pakistan Heart 90 2004 394 399
2. R.O. Bonow, B. Carabello, and C.R. McCay ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease) J. Am. Coll. Cardiol. 32 1998 1486 1588
3. S.A. Hunt, D.W. Baker, and M.H. Chin ACC/AHA guidelines for evaluation and management of chronic heart failure in the adult: executive summary Circulation 104 2001 2996 3007
4. J. Ross Jr. The timing of surgery for severe mitral regurgitation N. Engl. J. Med. 335 1996 1456 1458
5. T.M. Sutton, R.A.H. Stewart, and I.L. Gerber Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation J. Am. Coll. Cardiol. 41 2003 2280 2287
6. I.L. Gerber, R.A.H. Stewart, and M.E. Legget Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis Circulation 107 2003 1884 1890
7. Y. Seino, A. Ogawa, and T. Yamashita Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure Eur. J. Heart Fail. 6 2004 295 300
8. N.B. Schiller, P.M. Shah, and M. Crawford Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-dimensional Echocardiograms J. Am. Soc. Echocardiogr. 2 1989 358 367
9. M. Enriquez-Sarano, K.R. Bailey, and J.B. Seward Quantitative Doppler assessment of valvular regurgitation Circulation 87 1993 841 848
10. S.A. Hall, M.E. Brickner, and D.L. Willett Assessment of mitral regurgitation severity by Doppler color flow mapping of the vena contracta Circulation 95 1997 636 642
11. G. Thibault, C. Charbonneau, J. Bilodeau, E.L. Schiffrin, and R. Garcia Rat brain natriuretic peptide is localized in atrial granules and released into the circulation Am. J. Physiol. 263 1992 R301 R309
12. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N. Engl. J. Med. 347 2002 161 167
13. P.O. Collinson, S.C. Barnes, D.C. Gaze, G. Galasko, A. Lahiri, and R. Senior Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys™ 1010 and 2010 analysers Eur. J. Heart Fail. 6 2004 365 368